STAT3 and neoplasm: In a murine kidney cancer model (RENCA), sunitinib inhibited STAT3 activity in tumor associated MDSCs, and was found to reduce the expression of several STAT3 regulated pro-angiogenic genes (Kujawski et al., 2008; Xin et al., 2009).